热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
PE/Cyanine7 anti-mouse CD279 (PD-1) Antibody
产品名称：
PE/Cyanine7 anti-mouse CD279 (PD-1) Antibody
产品类别：
抗体
产品编号：
109109
产品应用：
109109
[价格]
规格 价格 库存
25µg ￥ 1540 1

产品详情

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse PD-1 transfected BHK cells
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE/Cyanine7 under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The CD279 antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is =1.0 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

The RMP1-30 antibody does not block the binding of PD-1 to B7-H1 and B7-DC1.

Additional Product Notes
BioLegend is in the process of converting the name PE/Cy7 to PE/Cyanine7. The dye molecule remains the same, so you should expect the same quality and performance from our PE/Cyanine7 products. Please contact Technical Service if you have any questions.
Application References

(PubMed link indicates BioLegend citation)
  1. Matsumoto K, et al. 2004. J. Immunol. 172:2530.
  2. Raimondi G, et al. 2006. J. Immunol. 176:2808. (FC) PubMed
  3. King IL, et al. 2009. J. Exp Med 206:1001. (FC) PubMed
Product Citations
  1. Lindenstr?m T, et al. 2013. J Immunol. 190:6311. PubMed
  2. Gern BH, et al. 2021. Cell Host Microbe. 29(4):594-606.e6. PubMed
  3. Vanderleyden I, et al. 2020. Cell Rep. 30:611. PubMed
  4. Singer M et al. 2016. Cell. 166(6):1500-1511 . PubMed
  5. Webb LMC, et al. 2021. Aging Cell. 20:e13295. PubMed
  6. Turner JS et al. 2018. Cell reports. 25(6):1395-1403 . PubMed
  7. Blecher-Gonen R, et al. 2019. Cell Syst. 8:109. PubMed
  8. Andrade MS, et al. 2022. JCI Insight. 7:. PubMed
  9. Low MSY, et al. 2019. Cell Reports. 29(9):2634-2645.e5. PubMed
  10. McLane LM, et al. 2021. Cell Reports. 35(6):109120. PubMed
  11. Acharya N, et al. 2020. Immunity. 53(3):658-671.e6. PubMed
  12. Shi J, et al. 2018. Immunity. 49:264. PubMed
  13. Wu M, et al. 2021. Nat Commun. 12:3500. PubMed
  14. Pérez‐Mazliah D et al. 2017. EBioMedicine. 24:216-230 . PubMed
  15. Elsner RA, et al. 2020. Cell Reports. 29(9):2796-2809.e5.. PubMed
  16. Mohrs I 2009. J Exp Med. 206:1001. PubMed
  17. Montes de Oca R, et al. 2021. Mol Cancer Ther. 20:1941. PubMed
  18. Chen JS, et al. 2022. Sci Immunol. 7:eabl5652. PubMed
  19. Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
  20. Biram A, et al. 2020. Cell Rep. 30:1910. PubMed
  21. Dangi T, et al. 2020. Curr Protoc Immunol. 130:e99. PubMed
  22. Suah AN, et al. 2021. J Clin Invest. 131:. PubMed
  23. Hilpert C, et al. 2016. J Immunol. 197: 2780 - 2786. PubMed
  24. Panciera T, et al. 2016. Cell Stem Cell. 19:725-737. PubMed
  25. Jeon S, et al. 2013. J Immunol. 190:6277. PubMed
  26. Siddiqui I et al. 2019. Immunity. 50(1):195-211 . PubMed
  27. Stump CT, et al. 2021. Open Biol. 11:210245. PubMed
  28. Hossain DMS, et al. 2018. J Clin Invest. 128:644. PubMed
  29. Verghese DA, et al. 2018. JCI Insight. 3:. PubMed
  30. Chen Z et al. 2019. Immunity. 51(5):840-855 . PubMed
  31. Myers DR et al. 2019. Cell reports. 27(6):1858-1874 . PubMed
  32. Wang Y, et al. 2021. Cell Rep. 35:108948. PubMed
  33. Gary E, et al. 2020. Vaccine. 3821:38. PubMed
  34. Volberding PJ, et al. 2021. Cell Reports. 35(8):109160. PubMed
  35. Ringel AE, et al. 2020. Cell. 183(7):1848-1866.e26. PubMed
  36. Sullivan JA, et al. 2020. Cell Rep. 30:1039. PubMed
  37. Jing Y, et al. 2020. Sci Adv. 6:eaax9455. PubMed
  38. Yadava K et al. 2019. Elife. 8 pii: e44821. PubMed
  39. , et al. 2021. Eur J Immunol. 51:2708. PubMed
  40. Fu G, et al. 2021. Nature. 595:724. PubMed
  41. Trefzer A, et al. 2021. Cell Reports. 34(6):108748. PubMed
  42. Gabriel SS, et al. 2021. Immunity. 54(8):1698-1714.e5. PubMed
  43. Van Gool F, et al. 2019. Immunity. 50:362. PubMed
  44. Jain RW, et al. 2018. Cell Rep. 25:3342. PubMed
  45. Alameh MG, et al. 2021. Immunity. 54:2877. PubMed
  46. Biram A, et al. 2020. Bio Protoc. e3562:10. PubMed
  47. Vardhana SA, et al. 2020. Nat Immunol. 1.584722222. PubMed
  48. Jin C, et al. 2019. Cell. 176:998. PubMed
  49. Ying Zhang et al. 2017. Cancer cell. 32(3):377-391 . PubMed
  50. Hilpert C, et al. 2019. J Immunol. 203:3068. PubMed
  51. Chatterjee S et al. 2017. Cell metabolism. 27(1):85-100 . PubMed
  52. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  53. Zotos D, et al. 2021. Nat Commun. 12:7160. PubMed
  54. Evgin L, et al. 2020. Nat Commun. 2.671527778. PubMed
  55. Etzerodt A, et al. 2019. J Exp Med. 216:2394. PubMed
  56. Xiao S, et al. 2020. Cell Reports. 32(2):107892. PubMed
  57. Wu S, et al. 2021. Nat Cancer. 2:189. PubMed
  58. Benci JL et al. 2019. Cell. 178(4):933-948 . PubMed
  59. Woodworth J, et al. 2014. J Immunol. 192:3247. PubMed
  60. Miyauchi K, et al. 2016. Nat Immunol. 17:1447-1458. PubMed
  61. Chen Z, et al. 2021. Cell. 184(5):1262-1280.e22. PubMed
  62. Benci JL et al. 2016. Cell. 167(6):1540-1554 . PubMed
  63. Sema Kurtulus et al. 2018. Immunity. 50(1):181-194 . PubMed
  64. Fan MY et al. 2018. Cell reports. 25(5):1204-1213 . PubMed
  65. Chen Y, et al. 2021. Nat Immunol. 22:996. PubMed
  66. Miyauchi K, et al. 2021. Nat Commun. 12:3789. PubMed
  67. McPhee C, et al. 2013. J Immunol. 191:4581. PubMed
  68. Filskov J, et al. 2019. Sci Rep. 9:14085. PubMed
  69. Xu C, et al. 2021. Cell Reports. 35(11):109235. PubMed
  70. Dubrot J, et al. 2021. Immunity. 54(3):571-585.e6. PubMed
  71. Lederer K, et al. 2020. Immunity. 53(6):1281-1295.e5. PubMed
  72. Liu D, et al. 2021. Immunity. 54:2245. PubMed
  73. Smith LK, et al. 2021. Elife. 10:. PubMed
  74. Christensen D, et al. 2016. Mucosal Immunol. 10.1038/mi.2016.28. PubMed
  75. Zander R, et al. 2020. Immunity. 51(6):1028-1042.e4.. PubMed
  76. Nawaf M, et al. 2017. J Immunol. 10.4049/jimmunol.1700088. PubMed
  77. Song W, et al. 2022. Immunity. 55:290. PubMed
RRID
AB_572016 (BioLegend Cat. No. 109109) AB_572017 (BioLegend Cat. No. 109110)

Antigen Details

Structure
Ig superfamily, 50-55 kD
Distribution

Subset of double negative thymocytes, activated T and B cells

Function
Lymphocyte clonal selection, peripheral tolerance
Ligand/Receptor
PD-L1 (B7-H1), PD-L2
Cell Type
B cells, T cells, Thymocytes, Tregs
Biology Area
Apoptosis/Tumor Suppressors/Cell Death, Cancer Biomarkers, Cell Biology, Immunology, Inhibitory Molecules
Molecular Family
CD Molecules, Immune Checkpoint Receptors
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Agata Y, et al. 1996. Int. Immunol. 8:765.
3. Nishimura H, et al. 2001. Science 291:319.
4. Ishida Y, et al. 1992. EMBO J. 11:3887.

Gene ID
18566 View all products for this Gene ID
UniProt
View information about CD279 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线